121
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Synergic Effect of Intravitreal Bevacizumab and Systemic Corticosteroid in Treating Systemic Inflammatory Response Syndrome (SIRS) Associated Purtscher-like Retinopathy

, MD & , MD
Pages 421-425 | Received 10 Aug 2021, Accepted 18 Dec 2021, Published online: 11 Apr 2022

References

  • Miguel AI, Henriques F, Azevedo LF, Loureiro AJ, Maberley DA. Systematic review of Purtscher’s and Purtscher-like retinopathies. Eye (Lond). 2013;27(1):1–13. doi:10.1038/eye.2012.222.
  • Agrawal A, McKibbin M. Purtscher’s retinopathy: epidemiology, clinical features and outcome. Br J Ophthalmol. 2007;91(11):1456–1459. doi:10.1136/bjo.2007.117408.
  • Tripathy K, Patel BC. Purtscher retinopathy. StatPearls. Treasure Island (FL); 2021.
  • Purtscher O. Noch Unbekannte Befunde Nach Schadeltrauma. Bericht Uber Die Zusammenkunft Der Deutschen Ophthalmologischen Gesellschaft. 1910;36:294–301.
  • Viola F, Vezzola D, Villani E, Mapelli C, Barteselli G, Ratiglia R. Purtscher-like retinopathy in septicemic disseminated intravascular coagulation associated with nephrotic syndrome. Eur J Ophthalmol. 2013;23(4):601–603. doi:10.5301/ejo.5000290.
  • Nesmith BL, Bitar MS, Schaal S. The anatomical and functional benefit of bevacizumab in the treatment of macular edema associated with Purtscher-like retinopathy. Eye (Lond). 2014;28(8):1038–1040. doi:10.1038/eye.2014.85.
  • Mariani AF, Major JC Jr., Brown DM, Wykoff CC, Benz MS, Kegley EN. Purtscher-like retinopathy associated with pemphigus vulgaris. Retin Cases Brief Rep. 2013;7(4):304–306. doi:10.1097/ICB.0b013e31828ef039.
  • Kunavisarut P, Pathanapitoon K, Rothova A. Purtscher-like retinopathy associated with systemic lupus erythematosus. Ocul Immunol Inflamm. 2016;24(1):60–68. doi:10.3109/09273948.2014.932816.
  • Chakraborty RK, Burns B. Systemic inflammatory response syndrome. StatPearls. Treasure Island (FL); 2021.
  • Robertson CM, Coopersmith CM. The systemic inflammatory response syndrome. Microbes Infect. 2006;8(5):1382–1389. doi:10.1016/j.micinf.2005.12.016.
  • Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/Society of critical care medicine. Chest. 1992;101(6):1644–1655.
  • Pinato DJ, Merli M, Dalla Pria A, et al. Systemic inflammatory response is a prognostic marker in HIV-infected patients with hepatocellular carcinoma. Oncology. 2017;93(6):395–400. doi:10.1159/000479521.
  • Masi P, Hekimian G, Lejeune M, et al. Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: insights from a prospective, single-center cohort study. Circulation. 2020;142(6):611–614. doi:10.1161/CIRCULATIONAHA.120.048925.
  • Laval K, Vernejoul JB, Van Cleemput J, Koyuncu OO, Enquist LW. Virulent pseudorabies virus infection induces a specific and lethal systemic inflammatory response in mice. J Virol. 2018;92(24):e01614–18.
  • Kincaid MC, Green WR, Knox DL, Mohler C. A clinicopathological case report of retinopathy of pancreatitis. Br J Ophthalmol. 1982;66(4):219–226. doi:10.1136/bjo.66.4.219.
  • Behrens-Baumann W, Scheurer G, Schroer H. Pathogenesis of Purtscher’s retinopathy. An experimental study. Graefes Arch Clin Exp Ophthalmol. 1992;230(3):286–291. doi:10.1007/BF00176306.
  • Agrawal A, McKibbin MA. Purtscher’s and Purtscher-like retinopathies: a review. Surv Ophthalmol. 2006;51(2):129–136. doi:10.1016/j.survophthal.2005.12.003.
  • Buckley SA, James B. Purtscher’s retinopathy. Postgrad Med J. 1996;72(849):409–412. doi:10.1136/pgmj.72.849.409.
  • Lai JC, Johnson MW, Martonyi CL, Till GO. Complement-induced retinal arteriolar occlusions in the cat. Retina. 1997;17(3):239–246. doi:10.1097/00006982-199717030-00011.
  • Camussi G, Tetta C, Bussolino F, et al. Mediators of immune complex-induced aggregation of polymorphonuclear neutrophils. I. C5a anaphylatoxin, neutrophil cationic proteins and their cleavage fragments. Int Arch Allergy Appl Immunol. 1980;62(1):1–15. doi:10.1159/000232478.
  • Craddock PR, Hammerschmidt D, White JG, Dalmosso AP, Jacob HS. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest. 1977;60(1):260–264. doi:10.1172/JCI108763.
  • Jacob HS, Goldstein IM, Shapiro I, Craddock PR, Hammerschmidt DE, Weissmann G. Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization. Arch Intern Med. 1981;141(1):134–136. doi:10.1001/archinte.1981.00340010126025.
  • Shapiro I, Jacob HS. Leukoembolization in ocular vascular occlusion. Ann Ophthalmol. 1982;14:60–62.
  • Ashton N, Henkind P. Experimental occlusion of retinal arterioles: using graded glass ballotini. Br J Ophthalmol. 1965;49:225–234. doi:10.1136/bjo.49.5.225.
  • Jimenez MF, Watson RWG, Parodo J, et al. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg. 1997;132(12):1263–1270. doi:10.1001/archsurg.1997.01430360009002.
  • Vezzola D, Allegrini D, Romano MR, et al. Optical coherence tomography angiography in Purtscher-like retinopathy associated with dermatomyositis: a case report. J Med Case Rep. 2019;13(1):206. doi:10.1186/s13256-019-2152-2.
  • Soliman W, Zibrandtsen N, Jørgensen T, Sander B, Alsbirk PH, Larsen M. Sequels of Purtscher’s retinopathy imaged by enhanced optical coherence tomography. Acta Ophthalmol Scand. 2007;85(4):450–453. doi:10.1111/j.1600-0420.2006.00851.x.
  • Hayreh SS, Weingeist TA. Experimental occlusion of the central artery of the retina. IV: retinal tolerance time to acute ischaemia. British J Ophthalmol. 1980;64(11):818–825. doi:10.1136/bjo.64.11.818.
  • Erikson K, Liisanantti JH, Hautala N, et al. Retinal arterial blood flow and retinal changes in patients with sepsis: preliminary study using fluorescein angiography. Crit Care. 2017;21(1):1–8. doi:10.1186/s13054-017-1676-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.